Settings
Light Theme
Dark Theme

Launching NFX Bio and The Rise of the Scientist Founder

Launching NFX Bio and The Rise of the Scientist Founder
Feb 2, 2021 · 24m 31s

Today we're announcing NFX Bio, a new fund initiative led by some of biotech's most successful Founder/CEOs. Our mission is to back seed-stage companies building bio-platforms that solve the biggest...

show more
Today we're announcing NFX Bio, a new fund initiative led by some of biotech's most successful Founder/CEOs. Our mission is to back seed-stage companies building bio-platforms that solve the biggest challenges facing humanity.

NFX Bio is led by Omri Amirav Drory, Ph.D., Founder/CEO of Genome Compiler (acquired by Twist Bioscience). Joining him on the Investment Committee is Emily LeProust, Ph.D., Co-Founder & CEO of Twist Bioscience (TWST - NASDAQ), as well as NFX GP's James Currier and Gigi Levy-Weiss.

By combining software/data tech with biology, and by architecting businesses with a platform approach, a whole new future of possibilities is unlocked.

Information technology has dominated human progress for forty years. And the next phase is going to be led by Scientist-Founders who build info-tech powered bio companies. The rise of the Scientist-Founder is now.

In this closed-door conversation, Omri, Emily, and James break down what they’re looking for, and what Scientists need to master in order to be CEOs.

Read the full NFX Essay here - https://www.nfx.com/post/launching-nfx-bio/
show less
Information
Author The NFX Podcast
Website -
Tags

Looks like you don't have any active episode

Browse Spreaker Catalogue to discover great new content

Current

Looks like you don't have any episodes in your queue

Browse Spreaker Catalogue to discover great new content

Next Up

Episode Cover Episode Cover

It's so quiet here...

Time to discover new episodes!

Discover
Your Library
Search